Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 323

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 323
---
3,810 | 11,130 |
| •Continuing operations                                                                            |         | 7,958 |  3,567 | 10,768 |
| •Discontinued operations                                                                          |         |    12 |    243 |    362 |
| Attributable to non-controlling interests                                                         |         |    80 |     23 |    118 |

| F-6 | SANOFIFORM 20-F2024 |

| 2024CONSOLIDATED FINANCIAL STATEMENTS        |
| Consolidated statements of changes in equity |

Consolidated statements of changes in equity

| (€ million)                                                                                                                         | Sharecapital | Additionalpaid-incapital | Treasuryshares | Reservesandretainedearnings | Stockoptions andother share-basedpayments | Othercomprehensiveincome | Attributableto equityholders ofSanofi | Attributableto non-controllinginterests | Totalequity |
| Balance atJanuary 1, 2022                                                                                                           |        2,527 |                      532 |           -939 |                      63,013 |                                     4,405 |                     -857 |                                68,681 |                                     350 |      69,031 |
| Other comprehensive incomefor the period                                                                                            |            — |                        — |              — |                         451 |                                         — |                    2,308 |                                 2,759 |                                       5 |       2,764 |
| Net income for the period                                                                                                           |            — |                        — |              — |                       8,371 |                                         — |                        — |                                 8,371 |                                     113 |       8,484 |
| Comprehensive incomefor the period                                                                                                  |            — |                        — |              — |                       8,822 |                                         — |                    2,308 |                                11,130 |                                     118 |      11,248 |
| Dividend paid out of 2021 earnings(€3.33per share)                                                                                  |            — |                        — |              — |                      -4,168 |                                         — |                        — |                                -4,168 |                                       — |      -4,168 |
| Effect of the distribution of anexceptional supplementary dividend of58% of the shares of EUROAPI to theequity holders of Sanofi(e) |            — |                        — |              — |                        -793 |                                         — |                        — |                                  -793 |                                       — |        -793 |
| Payment